These Council reports have proposed strategies to address high and escalating prescription drug prices and costs, including promoting transparency and pharmaceutical market competition, combating anti-competitive practices, and outlining criteria for value-based pricing and prescription drug importation.

Council on Medical Service Reports

Review reports and issue briefs prepared by the council. 

2022

Access all council reports prior to 2007 or learn more about the Council on Medical Service

 

Active State Undo
69
Featured Stories